TKNO

Alpha Teknova, Inc.

Nasdaq · In Vitro & In Vivo Diagnostic Substances · Inc. DE · CIK 0001850902
$4.65 +1.97% $249.3M
Insider Buying Cluster (2 insiders)High Impact Filing (7/10)
Vol
Market Cap$249.3M
Cap SizeMicro Cap
Inst. Holders7 funds
Inst. Value$3.8M
Inst. Activity2 buys / 1 sells
Insider Activity2B / 0S
Insider Net $$143.4K
SEC Reports4
Exchange Nasdaq·Sector In Vitro & In Vivo Diagnostic Substances·Inc. DE·CIK 0001850902·Prev Close $4.56

Recent Activity

Jun 1, 2026 SEC
Alpha Teknova filed an 8-K reporting that board member Irene Davis will not stand for re-election and will retire at the
8-K — Impact 2/10
Jun 1, 2026 Insider
DEMSKI MARTHA J sold 55,000 shares
Director @ $0.00 ($0.00)
Jun 1, 2026 Insider
ROBERTSON BRETT sold 55,000 shares
Director @ $0.00 ($0.00)
Jun 1, 2026 Insider
Vos Alexander sold 55,000 shares
Director @ $0.00 ($0.00)
May 6, 2026 SEC
Alpha Teknova reported Q1 2026 revenue of $11.1M (beat consensus of $10.2M by 8.6%) and EPS of -$0.08 (beat consensus -$
PRESS-RELEASE — Impact 7/10
Apr 22, 2026 SEC
Analysis based on filing metadata only — document content was unavailable. The press release announces an upcoming earni
PRESS-RELEASE — Impact 3/10
Inst.
MORGAN STANLEY — TRIM
75,667 shares ($287.5K)
Inst.
TWO SIGMA INVESTMENTS, LP — ADD
61,463 shares ($233.6K)

Price Targets

Historical data — last covering-analyst action Jul 2024. No current recommendation available.
$9.00 (Jul 2024)
Current $4.46 Low $7.00 Median $8.00 High $12.00 3 analysts
$7.00 $12.00

Analyst Ratings

Historical distribution75% buy · 12 analysts · last covering-analyst action Jul 2024
4Strong Buy
5Buy
3Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jul 10, 2024 Stephens & Co. REITERATE Overweight → Overweight
May 14, 2024 Stephens & Co. REITERATE Overweight → Overweight
Mar 12, 2024 BTIG DOWNGRADE Buy → Neutral
Jul 12, 2023 Keybanc INITIATE Sector Weight
Aug 11, 2022 Stephens & Co. MAINTAIN Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.07 $-0.07 — $-0.07 1
Next Q $-0.08 $-0.09 — $-0.08 -3% YoY 5
Current FY $-0.33 $-0.36 — $-0.29 2
Next FY $-0.24 $-0.29 — $-0.20 25% YoY 2

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$2.3M
BANK OF AMERICA CORP$862.9K
MORGAN STANLEY$287.5KTRIM
TWO SIGMA INVESTMENTS, LP$233.6KADD
CHARLES SCHWAB INVESTMENT MANAGEMENT$130.3KNEW

Recent Insider Trades

DateInsiderTypeValue
Jun 1, 2026DEMSKI MARTHAA$0.00
Jun 1, 2026ROBERTSON BRETTA$0.00
Jun 1, 2026Vos AlexanderA$0.00
Mar 6, 2026Gunstream StephenBUY$55.8K
Mar 6, 2026Lowell MatthewBUY$87.6K
7 institutional holders with $3.8M total value (1,004,071 shares) as of 2025-Q4. Top holders: VANGUARD, BANK, MORGAN. Net buying activity: 2 institutions added/increased vs 1 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC593,100$2.3M59.1%
2BANK OF AMERICA CORP /DE/227,085$862.9K22.6%
3MORGAN STANLEY75,667$287.5K7.5%TRIM -29.6%
4TWO SIGMA INVESTMENTS, LP61,463$233.6K6.1%ADD +66.1%
5CHARLES SCHWAB INVESTMENT MANAGEMENT INC34,298$130.3K3.4%NEW
6WELLS FARGO & COMPANY/MN11,883$45.2K1.2%ADD +43.8%
7FMR LLC575$2.2K0.1%DOUBLED +198.2%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MORGAN STANLEYTRIM107,52175,667-29.6%$287.5K2025-Q4
TWO SIGMA INVESTMENTS, LPADD36,99761,463+66.1%$233.6K2025-Q4
WELLS FARGO & COMPANY/MNADD8,26311,883+43.8%$45.2K2025-Q4
TWO SIGMA INVESTMENTS, LPTRIM70,49836,997-47.5%$229.0K2025-Q3
WELLS FARGO & COMPANY/MNADD5,7908,263+42.7%$51.1K2025-Q3
FMR LLCDOUBLED171510+198.2%$3.2K2025-Q3
RENAISSANCE TECHNOLOGIES LLCEXIT98,3650-100.0%$0.002025-Q3
UBS Group AGADD1,159,6461,586,310+36.8%$7.8M2025-Q2
MORGAN STANLEYADD79,244114,967+45.1%$564.5K2025-Q2
RENAISSANCE TECHNOLOGIES LLCDOUBLED47,70098,365+106.2%$483.0K2025-Q2
TWO SIGMA INVESTMENTS, LPNEW70,498$346.1K2025-Q2
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW34,270$168.3K2025-Q2
WELLS FARGO & COMPANY/MNNEW5,790$28.4K2025-Q2
MORGAN STANLEYDOUBLED28,97779,244+173.5%$411.3K2025-Q1
RENAISSANCE TECHNOLOGIES LLCTRIM67,02947,700-28.8%$247.6K2025-Q1
CITADEL ADVISORS LLCNEW21,422$111.2K2025-Q1
FMR LLCTRIM369200-45.8%$1.0K2025-Q1
TWO SIGMA INVESTMENTS, LPEXIT15,1480-100.0%$0.002025-Q1
UBS Group AGDOUBLED4511,113,196+246728.4%$9.3M2024-Q4
CITADEL ADVISORS LLCEXIT10,3820-100.0%$0.002024-Q4
6 unique insiders with 2 transactions. Net insider value: $143.4K ($143.4K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 1, 2026DEMSKI MARTHA JDirectorA55,000$0.00$0.00
Jun 1, 2026ROBERTSON BRETTDirectorA55,000$0.00$0.00
Jun 1, 2026Vos AlexanderDirectorA55,000$0.00$0.00
Mar 6, 2026Gunstream StephenPresident and CEOBUY26,000$2.15$55.8K
Mar 6, 2026Lowell MatthewChief Financial OfficerBUY40,000$2.19$87.6K
Feb 15, 2026Terrill DamonGeneral Counsel and CCOA148,000$0.00$0.00
Feb 15, 2026Gunstream StephenPresident and CEOA429,000$0.00$0.00
Feb 15, 2026Lowell MatthewChief Financial OfficerA171,000$0.00$0.00

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Jul 2024): 75% buy across 12 analysts — 4 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Jul 2024. No current recommendation available.
$9.00 mean target (Jul 2024)
$7.00 Low $12.00 High
MetricValue
Current Price$4.46
Target Low$7.00
Target Mean$9.00
Target Median$8.00
Target High$12.00
# Analysts3
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.07 $-0.07 $-0.07 $0.0B 6.0% 1
Next Q
2026-09-30
$-0.08 $-0.09 $-0.08 -2.5% +0.0% 1↑ 1↓ $0.0B 5.9% 5
Current FY
2026-12-31
$-0.33 $-0.36 $-0.29 1↑ 0↓ $0.0B 8.2% 2
Next FY
2027-12-31
$-0.24 $-0.29 $-0.20 24.6% $0.1B 14.7% 2

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.070
7d ago$0.000-0.070
30d ago$0.000-0.070
60d ago$0.000-0.070
90d ago$0.000-0.070
4 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 4 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jul 10, 2024 Stephens & Co. REITERATE Overweight Overweight
May 14, 2024 Stephens & Co. REITERATE Overweight Overweight
Mar 12, 2024 BTIG DOWNGRADE Buy Neutral
Jul 12, 2023 Keybanc INITIATE Sector Weight
Aug 11, 2022 Stephens & Co. MAINTAIN Overweight
Mar 16, 2022 Stephens & Co. MAINTAIN Overweight
Jul 20, 2021 Stephens & Co. INITIATE Overweight
Jul 20, 2021 Cowen & Co. INITIATE Outperform
Jul 20, 2021 BTIG INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20264530075%
May 1, 20264530075%
Apr 1, 20264530075%
Mar 1, 20264530075%
Feb 1, 20264530075%
Jan 1, 20264530075%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 6, 2026
earnings
Teknova Reports First Quarter 2026 Financial Results
<p align="center"><em>First quarter 2026 total revenue was $11.1 million, up 13% over the same quarter prior year</em><br><em>Company reaffirms 2026 r
May 6, 2026
earnings_calendar
TKNO Q1 2026 Earnings Scheduled — 2026-05-06
Apr 22, 2026
earnings
Teknova to Report First Quarter 2026 Financial Results on May 6, 2026
<p>HOLLISTER, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for
Feb 26, 2026
earnings_calendar
TKNO Q4 2025 Earnings After Market Close — 2026-02-26